Russell Investments Group
TLSI icon

Russell Investments Group’s TriSalus Life Sciences TLSI Stock Holding History

Russell Investments Group’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.3K Buy
15,441
+12,640
+451% +$50.2K ﹤0.01% 3540
2026
Q1 		$11.2K Buy
2,801
+72
+3% +$353 ﹤0.01% 3772
2025
Q4 		$19K Hold
2,729
– – ﹤0.01% 3641
2025
Q3 		$12.7K Buy
+2,729
New +$12.8K ﹤0.01% 3726

Other funds holding TLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group's TLSI Position: Q2 2026 in Review

Russell Investments Group increased its TriSalus Life Sciences (TLSI) stake by 451% in Q2 2026, buying an estimated $50.2K and bringing the position to 15,441 shares worth $70.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3540.

Russell Investments Group first reported a position in TLSI in Q3 2025 and has held it in 4 quarters since. 38 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Russell Investments Group held 15,441 shares of TriSalus Life Sciences worth $70.3K as of Q2 2026.
  • Russell Investments Group bought 12,640 TriSalus Life Sciences shares in Q2 2026, an estimated $50.2K.
  • TriSalus Life Sciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3540 holding.
  • Russell Investments Group first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 38 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.